Factors associated with the development of severe asthma
The results provide a clinically relevant risk factor profile for early identification of the patients at risk of developing severe asthma.
Authors
- Arja Viinanen (ORCID: https://orcid.org/0000-0003-4990-6228)
- Tero Ylisaukko‐oja
- Hannu Kankaanranta (ORCID: https://orcid.org/0000-0001-5258-0906)
- Pinja Ilmarinen (ORCID: https://orcid.org/0000-0002-8758-2431)
- Juulia Jylhävä (ORCID: https://orcid.org/0000-0003-0250-4491)
- J Idänpään-Heikkilä (ORCID: https://orcid.org/0000-0003-3762-5357)
- Lauri Lehtimäki (ORCID: https://orcid.org/0000-0003-1586-4998)
- Juha Mehtälä (ORCID: https://orcid.org/0000-0003-4088-8561)
Institutions
- Seinäjoki University of Applied Sciences (FI)
- Turku University Hospital (FI)
- Glaxosmithkline (Finland) (FI)
- Tampere University Hospital (FI)
- Tampere University (FI)
- United Medix Laboratories (Finland) (FI)
- Radiation and Nuclear Safety Authority (FI)
Publication Details
- Journal
- Annals of Allergy Asthma & Immunology
- Published
- 2025-03-09
- DOI
- https://doi.org/10.1016/j.anai.2025.03.002
- Citations
- 3
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.49
Funders
- GlaxoSmithKline